Multiple long-term follow-up studies confirm BRUKINSA’s superior efficacy and favorable tolerability versus ibrutinib in relapsed or refractory CLLAdditional ASH data from investigational BTK degrader ...

Charmin is making headlines again with its colossal Forever Roll, a 1,700-sheet toilet paper roll that the company claims is big enough to last an entire month, and tall enough—if unspooled—to rival ...

A growing network of at least 5,000 data centers across the US is becoming a hidden public health threat, scientists have warned. That is because the energy-hungry backbone of artificial intelligence ...

Heart problems can be a long-term side effect of radiation therapy. Radiation therapy may cause hypothyroidism, especially if it treats the neck, head, or chest. Pulmonary fibrosis can result from ...

CLN-049 monotherapy demonstrates promising efficacy, including multiple complete responses and encouraging response durability, in a heavily pretreated all-comer population of patients with R/R AML 31 ...

Lunsumio in combination with lenalidomide may offer an effective treatment in relapsed or refractory follicular lymphoma based on first data from single-arm US cohort of phase III CELESTIMO study1Data ...

Johnson & Johnson (NYSE:JNJ), the worldwide leader in multiple myeloma, today announced new data from the investigational Phase 3 MajesTEC-3 study that demonstrate the potential of TECVAYLI® ...

Promising efficacy and favorable safety data from the Phase 1 study in heavily pre-treated patients show potential of CLN-049 to address a broad ...

ALL is the most common childhood cancer, and cases are rising. Find out why this trend is paired with a remarkable 90% survival rate, and what public health action is needed next.

Despite TV screen sizes getting ever bigger in recent years, with some exceeding 100 inches, 32-inch is still the preferred option for many people shopping for a new set for their living room, or an ...